Page last updated: 2024-09-04

cyc 202 and nu6102

cyc 202 has been researched along with nu6102 in 4 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(nu6102)
Trials
(nu6102)
Recent Studies (post-2010) (nu6102)
979739332022

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)nu6102 (IC50)
Serine/threonine-protein kinase Chk1Homo sapiens (human)0.5
Cyclin-T1Homo sapiens (human)2.585
Rho-associated protein kinase 2Homo sapiens (human)0.6
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.0095
Cyclin-dependent kinase 1Homo sapiens (human)0.097
Cytochrome P450 3A4Homo sapiens (human)0.006
Cyclin-dependent kinase 4Homo sapiens (human)0.4087
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.1329
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.0074
Cyclin-A2Homo sapiens (human)0.1303
G1/S-specific cyclin-D1Homo sapiens (human)0.2598
G1/S-specific cyclin-E1Homo sapiens (human)0.0335
Cyclin-dependent kinase 2Homo sapiens (human)0.1041
Prostaglandin G/H synthase 2Homo sapiens (human)0.0081
Glycogen synthase kinase-3 betaHomo sapiens (human)0.04
Cyclin-dependent kinase 7Homo sapiens (human)3.7667
Cyclin-dependent kinase 9Homo sapiens (human)2.09
Cyclin-HHomo sapiens (human)3.45
CDK-activating kinase assembly factor MAT1Homo sapiens (human)2.5
Cyclin-A1Homo sapiens (human)0.0054
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.2985
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.9
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.117
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)0.8
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.0095
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.0074

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M1
Cheng, W; Kan, Q; Li, Y; Tian, X; Wang, S; Wei, H; Yang, Z1
Edwards, DP; Moore, NL; Weigel, NL1

Reviews

2 review(s) available for cyc 202 and nu6102

ArticleYear
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
    Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

    Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases

2018
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Animals; Crystallography, X-Ray; Cyclin-Dependent Kinases; Humans; Molecular Structure; Protein Binding; Protein Kinase Inhibitors

2019

Other Studies

2 other study(ies) available for cyc 202 and nu6102

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2014, Volume: 144 Pt B

    Topics: Breast Neoplasms; Cell Line, Tumor; Cyclin A2; Cyclin-Dependent Kinase 2; Female; Humans; Purines; Receptors, Progesterone; RNA, Messenger; Roscovitine

2014